Leicher Bruce 4
4 · MOMENTA PHARMACEUTICALS INC · Filed Feb 12, 2018
Insider Transaction Report
Form 4
Leicher Bruce
SVP & General Counsel
Transactions
- Exercise/Conversion
Common Stock
2018-02-08+5,381→ 178,380 total - Sale
Common Stock
2018-02-08$16.00/sh−1,861$29,776→ 176,519 total - Exercise/Conversion
Restricted Stock Units
2018-02-08−5,381→ 16,144 total→ Common Stock (5,381 underlying)
Footnotes (5)
- [F1]Shares received pursuant to settlement of Restricted Stock Units that were granted on February 7, 2017.
- [F2]Includes 480 shares acquired under the issuer's employee stock purchase plan at a purchase price of $14.07 per share on January 31, 2018.
- [F3]This transaction was effected pursuant to a Rule 10b5-1 trading plan.
- [F4]Restricted Stock Units convert into common stock on a one-for-one basis.
- [F5]Subject to certain criteria, the restricted stock units will vest with respect to 25% of the shares on the first anniversary of the grant date, and the remainder will vest in equal quarterly installments over the subsequent three years.